Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Scott B. Willoughby Insider Profile

4 Followers

Scott B. Willoughby, SVP, CLO, SECY at Sangamo Therapeutics, holds 647.37K shares in Sangamo Therapeutics (Ticker: SGMOQ).

Scott B. Willoughby's Trading History

SGMOQSangamo Therapeutics		May 27, 2026SVP, CLO, SECYUninformative Sell686.12$75.09K
SGMOQ
Insider Shares: 647.37K (0.16%)

Scott B. Willoughby has not reported any informative transactions for SGMOQ, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 27, 2026Uninformative Sell$686.124,036$0.17―
Feb 26, 2026Uninformative Sell$5.81K12,354$0.47―
Feb 26, 2026Uninformative Sell$775.501,650$0.47―
Jan 26, 2026Uninformative Sell$14.30K36,676$0.39―
Nov 26, 2025Uninformative Sell$834.352,035$0.41―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Scott B. Willoughby insider profile FAQ

What stocks does Scott B. Willoughby hold?
Scott B. Willoughby holds: SGMOQ stocks.
What was Scott B. Willoughby’s latest transaction?
Scott B. Willoughby’s latest transaction was an Uninformative Sell of $686.12.
What is Scott B. Willoughby's role in Sangamo Therapeutics?
Scott B. Willoughby's role in Sangamo Therapeutics is SVP, CLO, SECY.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.